ArticleFrontiers in oncology2025

Case Report: Apatinib combined with IMRT concurrent therapy achieves rapid response and significantly prolongs progression-free survival in elderly patients with inoperable locally advanced esophageal squamous cell carcinoma.

Juan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.